IDXX

SELL

IDEXX Laboratories, Inc.

Healthcare · Rank #115 · Analyzed Jul 13, 2026

$563.57

Current Price

$156.76

Intrinsic Value

-72.2%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 72.2%

Fair Value Range

Low$82.76

Base (IV)$156.76

High$211.40

Entry Points

Conservative$57.93

Moderate$82.76

Aggressive$109.73

Quality & Moat Breakdown

Return on Equity72.9% → 1.0/1.0

Debt LevelD/E 71 → 0/1.0

Revenue QualityGrowth 8.3%, margin Δ+5.1% → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins24.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.